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ABSTRACT  
Statin is recommended as the first line therapy for dyslipidaemia given its significant 
benefits for patients with high cardiovascular risk. Intensive lipid control using statin will aid 
in the prevention of CHD complications. Availability of various statin to choose is not an 
assurance to achieve lipid target. Therefore, the study sets out to investigate the trends and 
utilisation and prescribing pattern of statin drug in Hospital Serdang. As this thesis is mainly 
concerned on rosuvastatin users, the aim of this study is intended to determine the clinical 
characteristic of patients, evaluate the effects on lipid profile as well to determine the factors 
affecting LDL goal attainment of among those who were on rosuvastatin. A retrospective, 
observational study data collection was done at Hospital Serdang whereby the lists of all 
patients from 1 January 2015 to 31 Mac 2015 were retrieved from the eHIS system. Lipid 
profiles were obtained at baseline and 6 months follow up. Logistic regression analysis was 
used to predict factors for achieving target lipid goals. Findings from this study reveal that the 
top prescribing pattern of statin in Hospital Serdang is simvastatin 54.46%, followed by 
atorvastatin (37.12%), lovastatin (6%), rosuvastatin (2.15%) and pravastatin (0.28%). A total 
of 102 patients (aged ≥ 18 years) prescribed with rosuvastatin were included in this study 
which consist of 81 males and 21 females (mean age : 56.40 [±9.45]). The mean difference 
between pre and post LDL-C for rosuvasatin users (n=102) as well as patient who were 
prescribed with rosuvasatin as monotherapy (n=56) was significantly different ([95% CI- 
0.018, 0.442; p=0.048] and [95% CI- 0.113, 0.704; p=0.008]). Only 38.2% of patients 
achieved the target LDL-C goal attainment. In addition, there are significant association 
between LDL-C goal attainment with LDL-C at baseline level as well as TC level and CHD 
risk (p<0.05). TC level at baseline was the significant predictors for LDL-C goal attainment 
(p<0.05). In conclusion, patients (n=102) undergoing rosuvastatin treatment in the present 
study were unable to achieve targeted LDL-C goal attainment specifically patient with high 
TC. As variations may exist in achieving therapeutic goal attainment, future research with 
larger population is needed to compare the effects of all statin in lipid profile. 
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